Telehealth startup Antidote Health has raised $12 million in seed funding to build an AI-based virtual health maintenance organization (HMO), the company announced Wednesday. The round was led by iAngels, Well-Tech Ventures and Flint Capital, along with other angel investors.
Follow Israel Hayom on Facebook and Twitter
Antidote Health is a B2C company that launched in January, providing uninsured and underinsurance Americans with a virtual HMO via Artificial Intelligence that connects users to doctors with a smart chatbot and through video calls. Antidote Health chose an HMO model based on the belief that it is the right way to rectify the prevalent problem of access to healthcare in the US market, where over 38 million Americans are uninsured. Antidote is able to provide individuals premium quality health coverage for as little as $29 per month.
"Healthcare in the United States presents us with a great opportunity – both economically and morally. Making medical services available to a population of millions is an enormous mission," said Avihai Soudri, Antidote Health's co-founder and CEO.
"The convergence of two disciplines - AI-based virtual healthcare and Fin-tech (Insure-tech) applicational layers is unique in the technological-medical landscape in that it provides a disruptive force in the market. The melding of advanced technologies and the social impact Antidote produces are part of our organizational DNA and manifest in every action we take," Soudri said.
